A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Oxolamine Citrate | CAS 1949-20-8 - Request Quote

Picture of Oxolamine Citrate

Oxolamine Citrate

SZ CAT No:SZ-O010002
CAS No
1949-20-8
Mol.F.
C14H19N3O : C6H8O7
Mol.Wt.
245.3 : 192.1
Inv. Status
In Stock
Rel. CAS No959-14-8 (free base)

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Oxolamine Citrate is chemically N,N-Diethyl-3-phenyl-1,2,4-oxadiazole-5-ethanamine 2-Hydroxy-1,2,3-propanetricarboxylate. Oxolamine Citrate is supplied with detailed characterization data compliant with regulatory guideline. Oxolamine Citrate can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Oxolamine.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 1949-20-8

Purchase 1949-20-8

Order 1949-20-8

Enquire 1949-20-8

price of 1949-20-8

1949-20-8 Supplier

1949-20-8 Manufacturer

1949-20-8 Exporter

buy high quality Oxolamine Citrate

Purchase Oxolamine Citrate

Oxolamine Citrate suppliers

Oxolamine Citrate manufacturers

Oxolamine Citrate price

Order Oxolamine Citrate

Enquire Oxolamine Citrate

Oxolamine Citrate cost

Oxolamine Citrate Supplier

Oxolamine Citrate Distributor

Oxolamine Citrate for Method Validation

Oxolamine Reference Standard

Oxolamine Citrate for ANDA Filing

Oxolamine Citrate for Forced Degradation Studies

Oxolamine Citrate Identification Standards

Oxolamine Citrate for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,